4A4E image
Entry Detail
PDB ID:
4A4E
Title:
Solution structure of SMN Tudor domain in complex with symmetrically dimethylated arginine
Biological Source:
Source Organism:
Host Organism:
PDB Version:
Deposition Date:
2011-10-12
Release Date:
2011-11-30
Method Details:
Experimental Method:
Conformers Calculated:
200
Conformers Submitted:
20
Selection Criteria:
LOWEST ENERGY
Macromolecular Entities
Polymer Type:polypeptide(L)
Description:SURVIVAL MOTOR NEURON PROTEIN
Chain IDs:A
Chain Length:64
Number of Molecules:1
Biological Source:HOMO SAPIENS
Ligand Molecules
Primary Citation
Structural Basis for Dimethyl-Arginine Recognition by the Tudor Domains of Human Smn and Spf30 Proteins
Nat.Struct.Mol.Biol. 18 1414 ? (2011)
PMID: 22101937 DOI: 10.1038/NSMB.2185

Abstact

Arginine dimethylation plays critical roles in the assembly of ribonucleoprotein complexes in pre-mRNA splicing and piRNA pathways. We report solution structures of SMN and SPF30 Tudor domains bound to symmetric and asymmetric dimethylated arginine (DMA) that is inherent in the RNP complexes. An aromatic cage in the Tudor domain mediates dimethylarginine recognition by electrostatic stabilization through cation-π interactions. Distinct from extended Tudor domains, dimethylarginine binding by the SMN and SPF30 Tudor domains is independent of proximal residues in the ligand. Yet, enhanced micromolar affinities are obtained by external cooperativity when multiple methylation marks are presented in arginine- and glycine-rich peptide ligands. A hydrogen bond network in the SMN Tudor domain, including Glu134 and a tyrosine hydroxyl of the aromatic cage, enhances cation-π interactions and is impaired by a mutation causing an E134K substitution associated with spinal muscular atrophy. Our structural analysis enables the design of an optimized binding pocket and the prediction of DMA binding properties of Tudor domains.

Legend

Protein

Chemical

Disease

Primary Citation of related structures